Clinical trial
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to…
NCT00448227 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00448227 |
|---|---|
| Title | Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection |
| Official title | A Multicenter, Open-label, Single-arm Study to Evaluate the Single-dose Pharmacokinetics, Acceptability and Safety of Famciclovir Oral Pediatric Formulation in Infants 1 Month to Less Than 1 Year of Age With Herpes Simplex Virus Infections |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Simplex |
| Intervention type | Drug |
| Interventions | famciclovir |
| Enrollment | 18 |
| Start date | Oct 1, 2007 |
| Primary completion | Nov 1, 2008 |
| First posted | Mar 16, 2007 |
| Last update posted | Feb 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: